CannAssist International (CNSC) Corporate Media Kit

OUR STORY In 2015, Founder, Mark Palumbo continued to suffer from chronic pain after multiple back surgeries. Knowing the risk of long-term opiate use, Mark began to research alternative pain management options. The more Mark learned, the more interested he became in CBD and the prospect of using a natural pain aid. However, the more product Mark tried, the more frustrating it became. Marketed product performance widely varied, and labels rarely represented what actual testing showed. Convinced there was a better solution, Mark used his bioscience and formulating background to search for an answer. After more than two years of trials, Mark discovered processes and formulation techniques that consistently produced measurable results. The culmination of these efforts resulted in Xceptor Labs’ proprietary CBD-based formula, CiBiDinol.